Twenty-Two Cases of Rare Myocarditis by February 2021, Yet Pfizer Said No “New Safety Issues.” FDA Waits Until June 25, 2021, to Include Myocarditis Risk in Fact Sheets.
Twenty-Two Cases of Rare Myocarditis by February 2021, Yet Pfizer Said No “New Safety Issues.” FDA Waits Until June 25, 2021, to Include Myocarditis Risk in Fact Sheets.
As initially reported by Chris Flowers, M.D., on DailyClout.io in April 2022, myocarditis - inflammation of the heart muscle (a.k.a., myocardium) that can reduce the heart's ability to pump blood as well as cause chest pain, shortness of breath, and rapid or irregular heart rhythms (a.k.a., arrhythmias) [
https://www.youtube.com/watch?v=ezMKm-GwBN8&list=PL6mJJGI9Nksy62YBEROsbQCMaslFTmnAc&index=2 #Endthemandates #Dearunvaccinatedppl Endthemandates. Dearunvaccinatedppl. People are still being forced out. In a few short day municipal workers in NYC will lose their jobs.